Divergent pathways for TNF and C(2)-ceramide toxicity in HTC hepatoma cells.
暂无分享,去创建一个
N. Schiavone | S. Capaccioli | U. Brunk | R. Autelli | G. Bonelli | F. Baccino | S. Crepaldi | Chiara Ullio | E. Prigione
[1] U. Brunk,et al. Lysosomes and oxidative stress in aging and apoptosis. , 2008, Biochimica et biophysica acta.
[2] You-Sun Kim,et al. TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. , 2007, Molecular cell.
[3] V. Turk,et al. Lysosomal cysteine cathepsins: signaling pathways in apoptosis , 2007, Biological chemistry.
[4] C. Harris,et al. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer , 2007, Oncogene.
[5] J. Cidlowski,et al. Glucocorticoids inhibit the apoptotic actions of UV-C but not Fas ligand in hepatoma cells: direct evidence for a critical role of Bcl-xL , 2007, Cell Death and Differentiation.
[6] S. Conzen,et al. Dexamethasone inhibits TRAIL-induced apoptosis of thyroid cancer cells via Bcl-xL induction. , 2006, European journal of cancer.
[7] H. Lee,et al. Dexamethasone protects primary cultured hepatocytes from death receptor-mediated apoptosis by upregulation of cFLIP , 2006, Cell Death and Differentiation.
[8] Guido Kroemer,et al. Lysosomes and autophagy in cell death control , 2005, Nature Reviews Cancer.
[9] M. Parola,et al. Intracellular free iron and acidic pathways mediate TNF-induced death of rat hepatoma cells , 2005, Apoptosis.
[10] Zahra Zakeri,et al. Apoptosis, autophagy, and more. , 2004, The international journal of biochemistry & cell biology.
[11] D. Kabelitz,et al. Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. , 2004, Immunity.
[12] G. Kroemer,et al. Lysosomes and mitochondria in the commitment to apoptosis: a potential role for cathepsin D and AIF , 2004, Cell Death and Differentiation.
[13] J. Eaton,et al. Intralysosomal iron: a major determinant of oxidant-induced cell death. , 2003, Free radical biology & medicine.
[14] Y. Hannun,et al. Ceramide in apoptosis: an overview and current perspectives. , 2002, Biochimica et biophysica acta.
[15] R. Kerwin,et al. Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters , 2001, British journal of pharmacology.
[16] Mingde Zhao,et al. Sphingosine-induced apoptosis is dependent on lysosomal proteases. , 2001, The Biochemical journal.
[17] Marcel Leist,et al. Four deaths and a funeral: from caspases to alternative mechanisms , 2001, Nature Reviews Molecular Cell Biology.
[18] S. Friedman,et al. Expression and role of Bcl‐xL in human hepatocellular carcinomas , 2001, Hepatology.
[19] W. Bursch. The autophagosomal–lysosomal compartment in programmed cell death , 2001, Cell Death and Differentiation.
[20] J. Gugenheim,et al. Dexamethasone inhibits spontaneous apoptosis in primary cultures of human and rat hepatocytes via Bcl-2 and Bcl-xL induction , 2001, Cell Death and Differentiation.
[21] J. Cidlowski,et al. Delineation of an Antiapoptotic Action of Glucocorticoids in Hepatoma Cells: The Role of Nuclear Factor-κB. , 2000, Endocrinology.
[22] J. Medin,et al. Stress‐induced apoptosis is not mediated by endolysosomal ceramide , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] B. Aggarwal,et al. TNF-Induced Signaling in Apoptosis , 1999, Journal of Clinical Immunology.
[24] M. Peter,et al. Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.
[25] J. Cidlowski,et al. Dominant suppression of lymphocyte apoptosis by hepatoma cells. , 1997, Experimental cell research.
[26] C. Borner,et al. Bcl-2 interrupts the ceramide-mediated pathway of cell death. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] P. Petit,et al. Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis , 1995, The Journal of cell biology.
[28] K. Sandhoff,et al. The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts. , 1994, Biological chemistry Hoppe-Seyler.
[29] H. Land,et al. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.
[30] A. Roscher,et al. Evidence for lysosomotropic action of desipramine in cultured human fibroblasts. , 1983, The Journal of pharmacology and experimental therapeutics.
[31] J. Cidlowski,et al. Delineation of an antiapoptotic action of glucocorticoids in hepatoma cells: the role of nuclear factor-kappaB. , 2000, Endocrinology.